U.S. FDA completes inspection of Lupin’s Aurangabad facility with Zero observation
Minister K.T Rama Rao inaugurates Syngene’s new R&D centre in Genome Valley, Hyderabad
Zhejiang Hisun Pharma gets approval for clinical trial to test flu drug Favipiravir for pneumonia caused by new coronavirus
Former Vice President and Managing Director, South Asia Region, MSD India, KG Ananthakrishnan appointed new Director General of OPPI
US FDA Inspection at Aurobindo Pharma’s injectable formulation manufacturing facility- Unit IV
Mr Ambati Venu taking up a new role as Vice President, Established Pharmaceutical Products, within the Abbott Group in India with effect from March 1, 2020
